Skip to Content
Opening Bell

Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

1MPast Month3MPast 3 Months6MPast 6 MonthsYTDYear to Date1YPast Year5YPast 5 Years
Selected5Y Return
  • AKROAkero Therapeutics Inc+ 118.34%
  • BIAFbioAffinity Technologies Inc− 99.52%

    Partial Period · Aug 29, 2022 — Aug 31, 2026

  • MRNAModerna Inc− 67.61%

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

AKRO+ 118.3%BIAF− 99.5%MRNA− 67.6%Tap or hover the chart for values along the way
MetricAKROBIAFMRNA
Return
Last Price—15.27—
Daily Change—+ 19.48%—
Period ReturnPast 5 Years
+ 118.34%
− 99.52%Aug 29, 2022 — Aug 31, 2026
− 67.61%
Valuation
Market Cap$4.50 B$3.24 M$57.5 B
P/E Ratio———
Dividend Yield———
Net MarginTrailing 12M—257.3%141.4%
Risk
Beta0.90-1.361.22
52-Week Range41.77 — $54.834.56 — $202.5022.28 — $176.66

Company

  • AKROBiotechnology
  • BIAFBiotechnology
  • MRNAHealth Care · Biotechnology

FinnhubUpdated 23:00

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.